{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:52:01Z","timestamp":1773071521970,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2015,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/ki.2010.22","type":"journal-article","created":{"date-parts":[[2010,2,24]],"date-time":"2010-02-24T08:44:44Z","timestamp":1267001084000},"page":"1000-1009","source":"Crossref","is-referenced-by-count":107,"title":["Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes"],"prefix":"10.1016","volume":"77","author":[{"given":"Dilip K.","family":"Deb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari E.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.22_bb0010","first-page":"F477","article-title":"Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations","volume":"265","author":"Anderson","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2010.22_bb0015","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1046\/j.1523-1755.2000.00416.x","article-title":"Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat","volume":"58","author":"Zimpelmann","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.ASN.0000060804.40201.6E","article-title":"Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose","volume":"14","author":"Singh","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.22_bb0025","doi-asserted-by":"crossref","first-page":"F1039","DOI":"10.1152\/ajprenal.00371.2003","article-title":"High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells","volume":"286","author":"Vidotti","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2010.22_bb0030","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.ki.5002195","article-title":"Activation of the renin-angiotensin system within podocytes in diabetes","volume":"71","author":"Yoo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1523-1755.2000.00879.x","article-title":"Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients","volume":"57","author":"Chan","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.22_bb0045","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.22_bb0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.22_bb0055","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1523-1755.2000.00880.x","article-title":"Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy","volume":"57","author":"Andersen","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0060","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.22_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2215\/CJN.01201005","article-title":"Direct renin inhibition with aliskiren in hypertension and target organ damage","volume":"1","author":"Muller","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.22_bb0070","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.22_bb0075","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1172\/JCI119000","article-title":"Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver","volume":"98","author":"Veniant","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.22_bb0080","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1073\/pnas.0803751105","article-title":"Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2010.22_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.22_bb0090","doi-asserted-by":"crossref","first-page":"F1212","DOI":"10.1152\/ajprenal.00002.2009","article-title":"1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway","volume":"296","author":"Deb","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2010.22_bb0095","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2010.22_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsbmb.2005.02.008","article-title":"Analogs of 1alpha,25-dihydroxyvitamin D3 as novel inhibitors of renin biosynthesis","volume":"96","author":"Qiao","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/ki.2010.22_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000104875","article-title":"Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57\/BL6 mice","volume":"106","author":"Fryer","year":"2007","journal-title":"Nephron Physiol"},{"key":"10.1038\/ki.2010.22_bb0110","doi-asserted-by":"crossref","first-page":"F1138","DOI":"10.1152\/ajprenal.00315.2002","article-title":"Diabetic kidney disease in the db\/db mouse","volume":"284","author":"Sharma","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2010.22_bb0115","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","article-title":"From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy","volume":"54","author":"Wolf","year":"2005","journal-title":"Diabetes"},{"key":"10.1038\/ki.2010.22_bb0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1440-1797.2006.00583.x","article-title":"Role of podocyte slit diaphragm as a filtration barrier","volume":"11","author":"Kawachi","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1038\/ki.2010.22_bb0125","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/sj.ki.5001624","article-title":"Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy","volume":"70","author":"Wang","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.abb.2007.02.031","article-title":"Leptin attenuates gene expression for renal 25-hydroxyvitamin D3-1alpha-hydroxylase in mice via the long form of the leptin receptor","volume":"463","author":"Matsunuma","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/ki.2010.22_bb0135","doi-asserted-by":"crossref","first-page":"F791","DOI":"10.1152\/ajprenal.00247.2009","article-title":"Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist","volume":"297","author":"Zhang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2010.22_bb0140","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","article-title":"The podocyte's response to injury: role in proteinuria and glomerulosclerosis","volume":"69","author":"Shankland","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0145","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2006080872","article-title":"Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes","volume":"18","author":"Perkins","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.22_bb0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM198407123110204","article-title":"Predicting diabetic nephropathy in insulin-dependent patients","volume":"311","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.22_bb0155","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","article-title":"Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus","volume":"1","author":"Viberti","year":"1982","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.22_bb0160","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.1038\/ki.2010.22_bb0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1523-1755.2001.059002415.x","article-title":"Transcription factor-kappa B (NF-kappa B) and renal disease","volume":"59","author":"Guijarro","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0175","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1043-2760(03)00111-5","article-title":"The intrarenal renin-angiotensin system and diabetic nephropathy","volume":"14","author":"Carey","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/ki.2010.22_bb0180","series-title":"Kidney Int","article-title":"Renoprotective effects of vitamin D analogs","author":"Li","year":"2009"},{"key":"10.1038\/ki.2010.22_bb0185","doi-asserted-by":"crossref","first-page":"E820","DOI":"10.1152\/ajpendo.90763.2008","article-title":"Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins","volume":"296","author":"Wong","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2010.22_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ki.5002572","article-title":"Renoprotective role of the vitamin D receptor in diabetic nephropathy","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.22_bb0195","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/01.ASN.0000054498.83125.90","article-title":"Amelioration of diabetic nephropathy in SPARC-null mice","volume":"14","author":"Taneda","year":"2003","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381554163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381554163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T07:05:09Z","timestamp":1558854309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381554163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S008525381554163X"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.22","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.6752956.6918054","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}